Karl Werdan Selected Research

Counterpulsation (External Counterpulsation)

2/2022	[Cardiogenic shock complicating myocardial infarction].
6/2020	Impact of timing of intraaortic balloon counterpulsation on mortality in cardiogenic shock - a subanalysis of the IABP-SHOCK II trial.
6/2020	Impact of timing of intraaortic balloon counterpulsation on mortality in cardiogenic shock - a subanalysis of the IABP-SHOCK II trial.
1/2019	Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial.
4/2015	Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
3/2015	Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
11/2013	Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.
10/2012	Intraaortic balloon support for myocardial infarction with cardiogenic shock.
6/2012	Intra-aortic balloon counterpulsation in the treatment of infarction-related cardiogenic shock--review of the current evidence.
6/2012	Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karl Werdan Research Topics

Disease

31	Cardiogenic Shock 12/2021 - 10/2004
29	Myocardial Infarction 12/2021 - 12/2003
23	Shock 02/2022 - 01/2010
16	Sepsis (Septicemia) 08/2015 - 02/2002
14	Multiple Organ Failure (MODS) 03/2022 - 04/2005
13	Inflammation (Inflammations) 05/2022 - 03/2006
13	Heart Failure 01/2016 - 04/2002
10	Infarction (Infarctions) 02/2022 - 10/2009
10	Thrombosis (Thrombus) 01/2014 - 06/2008
10	Atherosclerosis 04/2011 - 04/2004
9	Hypertension (High Blood Pressure) 04/2017 - 01/2002
9	Coronary Artery Disease (Coronary Atherosclerosis) 08/2010 - 11/2002
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2016 - 11/2005
7	Septic Shock (Toxic Shock Syndrome) 10/2020 - 02/2002
7	Critical Illness (Critically Ill) 01/2018 - 09/2005
7	Stable Angina 04/2017 - 10/2010
7	Necrosis 01/2017 - 01/2006
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2016 - 10/2006
4	Ischemia 03/2022 - 10/2006
4	Cardiomyopathies (Cardiomyopathy) 10/2016 - 01/2007
4	Bradycardia 09/2012 - 04/2006
3	Thromboembolism 12/2021 - 09/2010
3	Stroke (Strokes) 01/2019 - 09/2008
3	Pneumonia (Pneumonitis) 01/2018 - 03/2005
3	Diabetes Mellitus 11/2016 - 04/2004
3	Coronary Disease (Coronary Heart Disease) 07/2014 - 02/2010
3	Reperfusion Injury 04/2013 - 10/2006
3	Hemorrhage 08/2012 - 09/2008
2	Low Cardiac Output 01/2018 - 01/2014
2	Endocarditis 10/2016 - 01/2011
2	ST Elevation Myocardial Infarction 02/2016 - 06/2012
2	Obesity 01/2016 - 04/2004
2	Cardiac Arrhythmias (Arrythmia) 01/2014 - 11/2009
2	Atrial Fibrillation 08/2013 - 09/2008
2	Neoplasms (Cancer) 11/2012 - 09/2008
2	Thrombocytopenia (Thrombopenia) 06/2009 - 06/2009
2	Body Weight (Weight, Body) 08/2008 - 03/2008

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 11/2019 - 04/2002
10	IvabradineIBA 01/2018 - 10/2010
10	Proteins (Proteins, Gene)FDA Link 04/2013 - 12/2003
9	Interleukin-6 (Interleukin 6)IBA 01/2017 - 10/2003
8	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 06/2008
7	C-Reactive ProteinIBA 05/2022 - 02/2011
7	Messenger RNA (mRNA)IBA 04/2008 - 12/2003
6	CreatinineIBA 11/2016 - 10/2009
6	Enoxaparin (Lovenox)FDA LinkGeneric 01/2014 - 06/2008
6	AnticoagulantsIBA 01/2014 - 06/2008
5	Simendan (Levosimendan)IBA 01/2018 - 12/2007
5	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 05/2006
5	NitratesIBA 01/2016 - 10/2010
5	Interleukin-1 (Interleukin 1)IBA 12/2014 - 01/2006
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 04/2004
5	CatecholaminesIBA 05/2012 - 09/2005
4	Immunoglobulin G (IgG)IBA 01/2018 - 12/2007
4	EndotoxinsIBA 10/2016 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 07/2015 - 04/2008
4	Fondaparinux (Arixtra)FDA Link 01/2014 - 06/2008
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2011 - 09/2008
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2011 - 08/2006
3	Dobutamine FDA LinkGeneric 01/2018 - 12/2009
3	Pharmaceutical PreparationsIBA 04/2017 - 01/2013
3	FibrinIBA 01/2014 - 04/2010
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2013 - 10/2003
3	argatroban (MPQA)FDA Link 04/2010 - 06/2009
3	Fibrinogen (Factor I)FDA Link 06/2008 - 04/2004
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2020 - 08/2014
2	Vasodilator Agents (Vasodilators)IBA 01/2018 - 01/2014
2	SolutionsIBA 01/2018 - 01/2014
2	Clopidogrel (Plavix)FDA Link 12/2016 - 09/2008
2	Oxygen (Dioxygen)IBA 01/2016 - 01/2006
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2016 - 08/2013
2	Intravenous Immunoglobulins (IVIG)FDA Link 08/2015 - 12/2007
2	Antihypertensive Agents (Antihypertensives)IBA 06/2015 - 04/2011
2	CholesterolIBA 12/2014 - 01/2009
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2014 - 04/2002
2	cyclopropapyrroloindoleIBA 10/2013 - 08/2011
2	Interleukin-10 (Interleukin 10)IBA 05/2012 - 04/2002
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2012 - 12/2009
2	ExotoxinsIBA 01/2011 - 01/2002
2	AntithrombinsIBA 09/2010 - 04/2010
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2010 - 04/2009
2	Eptifibatide (Integrilin)FDA Link 04/2010 - 06/2008
2	Lipoproteins (Lipoprotein)IBA 02/2010 - 01/2006
2	Nitric Oxide Synthase (NO Synthase)IBA 10/2009 - 01/2002
2	bivalirudin (Angiomax)FDA Link 06/2009 - 10/2008
2	Triglycerides (Triacylglycerol)IBA 01/2009 - 01/2006

Therapy/Procedure

34	Therapeutics 01/2022 - 11/2005
15	Counterpulsation (External Counterpulsation) 02/2022 - 01/2008
13	Percutaneous Coronary Intervention 10/2017 - 04/2006
10	Critical Care (Surgical Intensive Care) 02/2022 - 10/2004
6	Catheters 04/2010 - 03/2006
5	Cardiac Catheters 01/2014 - 06/2008
4	Extracorporeal Circulation 01/2022 - 09/2021
4	Stents 01/2017 - 01/2007
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2012 - 04/2005
3	Extracorporeal Membrane Oxygenation 01/2022 - 02/2017
2	Length of Stay 05/2022 - 01/2014
2	Contraindications 01/2018 - 10/2011
2	Transcatheter Aortic Valve Replacement 10/2016 - 01/2014
2	Intravenous Infusions 01/2013 - 03/2008